Biopharmaceutical Analysis & Statistics, July 2014 (p4)

Talk to Clare

+1 339 368 6001

Publishers

All regions

You might be interested in: protein, biomedical, antibody, more »

91-130 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Tumor Necrosis Factor (TNF) Inhibitors -Pipeline Insights, 2014

Tumor Necrosis Factor (TNF) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Tumor Necrosis Factor (TNF) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biopharmaceutical
Tumor Necrosis Factor Receptor (TNFR) Antagonists -Pipeline Insights, 2014

Tumor Necrosis Factor Receptor (TNFR) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Tumor Necrosis Factor Receptor (TNFR) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biopharmaceutical
Vascular Adhesion Protein 1 (VAP-1) Inhibitors -Pipeline Insights, 2014

Vascular Adhesion Protein 1 (VAP-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vascular Adhesion Protein 1 (VAP-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Biopharmaceutical
Glucagon-Like Peptide 2 (GLP-2) Agonists -Pipeline Insights, 2014

Glucagon-Like Peptide 2 (GLP-2) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Glucagon-Like Peptide 2 (GLP-2) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biopharmaceutical
Heat Shock Protein 27 (Hsp27) Inhibitors -Pipeline Insights, 2014

Heat Shock Protein 27 (Hsp27) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Heat Shock Protein 27 (Hsp27) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biopharmaceutical
Heat Shock Protein 70 (Hsp70) Inhibitors -Pipeline Insights, 2014

Heat Shock Protein 70 (Hsp70) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Heat Shock Protein 70 (Hsp70) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biopharmaceutical
Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2014

Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Insulin Like Growth Factor 2 (IGF-2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biopharmaceutical
Protein Kinase C Beta (PKC-Beta) Inhibitors -Pipeline Insights, 2014

Protein Kinase C Beta (PKC-Beta) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Protein Kinase C Beta (PKC-Beta) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biopharmaceutical
Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors -Pipeline Insights, 2014

Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biopharmaceutical
Tumor Necrosis Factor Alpha (TNF-a) Agonists -Pipeline Insights, 2014

Tumor Necrosis Factor Alpha (TNF-a) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Tumor Necrosis Factor Alpha (TNF-a) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biopharmaceutical
Biotechnology Market in the United States

Biotechnology Market in the United States

  • $ 1 020
  • Industry report
  • June 2014
  • by Ibisworld

IBISWORLD INDUSTRY RISK RATINGS REPORT This is the replacement for IBISWorld's May Biotechnology in the US Industry Risk Ratings Report. Industry Risk Ratings Synopsis This Industry Risk Ratings report ...

  • Industries : Biopharmaceutical
  • Countries : United States
Sports Nutrition Market Overview in Romania

Sports Nutrition Market Overview in Romania

  • $ 898
  • Industry report
  • August 2014
  • by Euromonitor International

Sales of sports nutrition products remained negligible in 2009. Most sales were made in gyms, due to the very specific target audience of this category. Internet retailing was the second most popular distribution ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Romania
Sports Nutrition Market Analysis in Saudi Arabia

Sports Nutrition Market Analysis in Saudi Arabia

  • $ 898
  • Industry report
  • August 2014
  • by Euromonitor International

Consequently, a growing number of Saudi men began to lift weight and sought to build their muscles in order to create a well-toned appearance. This trend supported 9% current value growth in 2010 ove ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Saudi Arabia
Sports Nutrition Market Overview in Spain

Sports Nutrition Market Overview in Spain

  • $ 898
  • Industry report
  • August 2014
  • by Euromonitor International

La Caixa recently published a study regarding Spanish lifestyles. According to this study only four in 10 Spaniards practise some physical activity, and only two in 10 engage in sporting activity on a ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Spain
Sports Nutrition Market Analysis in Taiwan

Sports Nutrition Market Analysis in Taiwan

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

With economic recovery from the second half of 2009, sales of sports nutrition products increased, and in 2010 saw 2% growth in current value terms. Euromonitor International's report offers a comprehensive ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Taiwan
Sports Nutrition Market Overview in Brazil

Sports Nutrition Market Overview in Brazil

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

Creatine was released by ANVISA (Health Surveillance Agency) to be sold as sport nutrition in May 2010. Prior to that, creatine was classified a medicine by ANVISA and sports nutrition manufacturers had ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Brazil
Sports Nutrition Market Analysis in New Zealand

Sports Nutrition Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

This is evident in 2010’s growth of 1%, being lower than the review period CAGR of 4%. Euromonitor International's report offers a comprehensive guide to the size and shape of the industry at a national ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : New Zealand
Sports Nutrition in Hong Kong, China

Sports Nutrition in Hong Kong, China

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

Sports nutrition benefited from the health and wellness trend during the review period, with a growing number of consumers seeking to increase their participation in sports, lose weight and become healthier. ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : China
Sports Nutrition Market Overview in Slovakia

Sports Nutrition Market Overview in Slovakia

  • $ 898
  • Industry report
  • June 2014
  • by Euromonitor International

Sports nutrition continued to target mostly serious bodybuilders and athletes in Slovakia and continued to be perceived as a relative novelty. Sports nutrition is used by people who are physically active ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Slovakia (slovak Republic)
Sports Nutrition Market Analysis in Belgium

Sports Nutrition Market Analysis in Belgium

  • $ 898
  • Industry report
  • June 2014
  • by Euromonitor International

Demand was sustained by the recruitment of beginners, due to the popularisation of sport in Belgium, and the loyalty of sportsmen who already purchased such products. According to one player “Belgians ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Belgium
Quotient Biodiagnostics - Product Pipeline Analysis, 2014 Update

Quotient Biodiagnostics - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

Summary Quotient Biodiagnostics (Quotient) is a medical device company. The company develops, manufactures and markets immunohematology products. Its products include ABORh reagents, rare antisera, reagent ...

  • Industries : Biopharmaceutical
  • Countries : United States
The Binding Site Group Ltd. - Product Pipeline Analysis, 2014 Update

The Binding Site Group Ltd. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • August 2014
  • by Global Data

Summary The Binding Site Group Ltd. (Binding Site) is a privately-held medical device company. The company research, develops, manufactures and distributes immunodiagnostic assays for healthcare market. ...

  • Industries : Biopharmaceutical
Navidea Biopharmaceuticals, Inc. (formerly Neoprobe Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Navidea Biopharmaceuticals, Inc. (formerly Neoprobe Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
Accentia Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Accentia Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
PDL BioPharma, Inc. (formerly Protein Design Labs, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

PDL BioPharma, Inc. (formerly Protein Design Labs, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical, Sport Nutritional
Sun Biomedical Limited (Symbol:SBN) SWOT Analysis, Strategy, Revenues and Profits

Sun Biomedical Limited (Symbol:SBN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
Amano Enzyme Inc. SWOT Analysis, Strategy, Revenues and Profits

Amano Enzyme Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
BC Biomedical Laboratories Ltd. SWOT Analysis, Strategy, Revenues and Profits

BC Biomedical Laboratories Ltd. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada
BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
About 3 300 reports

Download Unlimited Documents from Trusted Public Sources

Adacel Technologies - Company Report, September 2014

  • Stock Summary
  • September 2014
    12 pages
  • Drug And Medica...  

    Biopharmaceutic...  

  • Australia  

View report >

Vaccine Market In The Us

September 2014

Vaccine Supply In Europe

September 2014

Antigen Market

September 2014

Vaccine Market

September 2014

29 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Abbott Laboratories

United States

Amgen Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.